Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-636-5 | CAS number: 77182-82-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jul - Oct 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
- Version / remarks:
- August 1982
- GLP compliance:
- no
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
- EC Number:
- 278-636-5
- EC Name:
- Ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
- Cas Number:
- 77182-82-2
- Molecular formula:
- C5H12NO4P.H3N
- IUPAC Name:
- ammonium 2-amino-4-[hydroxy(methyl)phosphoryl]butanoate
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoechst AG, Kastengrund, SPF breeding colony
- Age at study initiation: 7 - 8 weeks
- Weight at study initiation: 23 - 34 g, mean weigt 28.8 g (males), 21 - 29 g, mean weight 25.4 g (females)
- Assigned to test groups randomly: yes
- Housing: in fully air-conditioned rooms in Macrolon cages (Type 3), on softwood granulate in groups of 5 animals
- Diet (e.g. ad libitum): rat / mice diet Altromin 1324 (Altromin GmbH, Lage / Lippe), ad libitum
- Water (e.g. ad libitum): tap water in plastic bottles, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 10 %
- Photoperiod (hrs dark / hrs light): 12 h / 12 h
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: deionized water
- Concentration of test material in vehicle: 1.0 %, 2.0 % and 3.5 %
- Amount of vehicle (if gavage or dermal): 10 mL - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test compound dilutions were prepared fresh. Appropriate amounts were weight in a flask, mixed with deionized water and topped up to the calibration mark. A solution was formed.
- Duration of treatment / exposure:
- 24, 48, or 72 h
- Frequency of treatment:
- single treatment
- Post exposure period:
- 24, 48, or 72 h
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw (total dose)
- Dose / conc.:
- 100 mg/kg bw (total dose)
- Dose / conc.:
- 200 mg/kg bw (total dose)
- Dose / conc.:
- 350 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- Endoxan
- Route of administration: gavage
- Doses / concentrations: 50 mg/kg bw
Examinations
- Tissues and cell types examined:
- bone marrow, erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The dose levels for micronucleus testing were selected on the basis of a preliminary study to determine the acute toxicity and the maximal applicable dose. Oral administration of 400 mg test substance per kg body weight has caused partial lethality. Therefore, 350 mg/kg bw was selected for the main study as top dose level.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): The animals were treated once with the test compound and according to the test procedure were killed 24, 48 or 72 hours after administration of the test compound.
DETAILS OF SLIDE PREPARATION: For each animal, about 3 mL foetal bovine serum was poured into a centrifuge tube. Both femora were removed and the bones freed of muscle tissue. The proximal ends of the femora were opened and the bone marrow flushed into the centrifuge tube. A suspension was formed. The mixture was then centrifuged for 5 minutes at 1200 rpm and almost all the supernatant discarded. One drop of the thoroughly mixed sediment was smeared on a cleaned slide, identified by project code and animal number and air-dried for about 24 hours.
Staining procedure:
- 5 minutes in methanol
- 3 minutes in May-Grünwalds solution
- 2 minutes in May-Grünwalds solution diluted 1:1 with distilled water
- brief rinsing twice in distilled water
- 10 minutes staining in 1 part Giemsa solution to 6 parts buffer solution, pH 7.2 (Weise)
- rinsing in distilled water
- drying
- coating with Entellan
METHOD OF ANALYSIS: 1000 polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded, not the number of individual micronuclei. As a control measure 1000 mature erythrocytes were also counted and examined for micronuclei. In addition, the ratio of polychromatic to normochromatic erythrocytes was determined. All bone marrow smears for evaluation are coded to ensure that the group to which they belonged remains unknown to the investigator. The number of polychromatic erythrocytes with micronuclei occurring in the 1000 polychromatic erythrocytes counted, and the number of normocytes with micronuclei occurring in the 1000 normocytes counted, were evaluated statistically; comparison of dose groups with the simultaneous control group was performed according to Wilcoxon (paired, one-sided increase).
The results of the treatment groups (test substance) in the micronucleus test at each dose and killing time were compared with corresponding control values. The ratio of polychromatic to normochromatic erythrocytes was also evaluated statistically by the method of Wilcoxon (paired, two-sided). - Statistics:
- The statistical evaluations were performed using "Diamant" computer program Version 2.0, supplied by the Department of Information and Communication Hoechst AG. All statistical results are based on a 95 % level of significance. Actual data were also compared with historical controls.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not examined
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- All animals survived after application of 0, 100 and 200 mg test substance per kg boy weight. Application of 350 mg resulted in death of 2 females out of 30 animals treated. These animals were replaced by two females treated with 350 mg/kg bw and survived the treatment. The following signs of toxicity were observed with some of the animals at the top dose level: increased spontaneous activity, aggressivity, tactile hyperaesthesia, motor excitation, uncoordinated gait, narrowed palpebral fissures, clonic convulsions.
The two animals which did not survive the treatment of 350 mg test substance had panting, uncoordinated gait and abdominal position.
The dissection of the animals revealed no abnormal macroscopic findings with the except of yellow (foamy) liquid in the intestinal tract of 4/30 animals of the 350 mg/kg bw dose level.
The bone marrow smears were examined for the occurance of micronuclei in red blood cells.
The incidence of micronucleated polychromatic erythrocytes in the dose groups of the test substance was within the normal range of the negative control groups. Due to a low spontaneous control value in the negative control group (72 h killing time) a small statistically significant increase in the number of micronucleated polychromatic erythrocytes seemed to occur in female animals at 350 mg/kg bw. These numbers too were in the normal range of negative control values and were considered as of no toxicological significance. The number of normochromatic erythrocytes with micronuclei did not differ significantly from the values of the simultaneous control animals for each of the three killing times investigated. With most treatment groups the ratio of polychromatic erythrocytes to normocytes remained unaffected by the test compound. Only in females at the 72 hours killing time a statistically significant reduction in the ratio of polychromatic erythrocytes to normocytes was observed at 200 and 350 mg/kg bw.
Cyclophosphamid (Endoxan) induced a marked and statistically significant increase of the number of polychromatic erythrocytes with micronuclei in both males and females indicating the sensitivity of the test system.
Any other information on results incl. tables
Table 2: Summary of findings in bone marrow erythrocytes
Sex |
Dose [mg/kg bw] |
Sampling after dosing |
No. of animals |
Erythrocytes |
Erythrocytes with micronuclei |
|||||||||||||
Poly |
Normo |
P/N |
Poly (Mean) |
Normo (Mean) |
||||||||||||||
Mean |
Mean |
Mean |
SD |
|
NO |
% |
SD |
|
Mut.I. |
NO |
% |
SD |
|
Mut.I. |
||||
Male |
Control 100 200 350 P.Cont. |
24 h 24 h 24 h 24 h 24 h |
5 5 5 5 5 |
1000 1000 1000 1000 1000 |
1000 1000 1000 1000 1000 |
1.03 1.09 1.01 0.91 0.92 |
0.11 0.10 0.10 0.22 0.09 |
I - I - I - I - I |
3 4 2 2 65 |
0.34 0.36 0.24 0.20 6.46 |
0.05 0.23 0.17 0.07 1.34 |
I - I - I - I *A |
1.0 1.1 0.7 0.6 19.0 |
1 1 1 1 2 |
0.14 0.06 0.08 0.14 0.22 |
0.13 0.05 0.11 0.11 0.11 |
I - I - I - I - I |
1.0 0.4 0.6 1.0 1.6 |
Female |
Control 100 200 350 P.Cont. |
24 h 24 h 24 h 24 h 24 h |
5 5 5 5 5 |
1000 1000 1000 1000 1000 |
1000 1000 1000 1000 1000 |
1.31 1.37 1.29 1.29 0.88 |
0.16 0.21 0.06 0.26 0.15 |
A - (A) - (I) - (I) * (I) |
1 2 1 2 31 |
0.08 0.22 0.08 0.16 3.14 |
0.13 0.11 0.08 0.15 0.56 |
I - I - I - I *A |
1.0 2.8 1.0 2.0 39.3 |
1 2 2 1 2 |
0.12 0.16 0.16 0.12 0.18 |
0.08 0.09 0.09 0.16 0.04 |
I - I - I - I - I |
1.0 1.3 1.3 1.0 1.5 |
Male |
Control 100 200 350 |
48 h 48 h 48 h 48 h |
5 5 5 5 |
1000 1000 1000 1000 |
1000 1000 1000 1000 |
0.84 1.08 1.08 0.96 |
0.24 0.15 0.10 0.10 |
I - I - I - I |
3 3 3 3 |
0.32 0.34 0.30 0.32 |
0.13 0.13 0.12 0.23 |
I - I - I - I |
1.0 1.1 0.9 1.0 |
2 1 1 2 |
0.20 0.08 0.14 0.22 |
0.16 0.08 0.21 0.16 |
I - I - I - I |
1.0 0.4 0.7 1.1 |
Female |
Control 100 200 350 |
48 h 48 h 48 h 48 h |
5 5 5 5 |
1000 1000 1000 1000 |
1000 1000 1000 1000 |
1.17 1.03 1.12 1.26 |
0.17 0.21 0.22 0.15 |
I - I - I - I |
2 2 2 2 |
0.20 0.16 0.22 0.22 |
0.16 0.15 0.13 0.13 |
I - I - I - I |
1.0 0.8 1.1 1.1 |
3 1 1 3 |
0.26 0.14 0.10 0.30 |
0.15 0.11 0.07 0.20 |
I - I - I - A |
1.0 0.5 0.4 1.2 |
Male |
Control 100 200 350 |
72 h 72 h 72 h 72 h |
5 5 5 5 |
1000 1000 1000 1000 |
1000 1000 1000 1000 |
1.01 1.17 0.89 0.83 |
0.18 0.18 0.14 0.24 |
I - I - I - I |
2 2 3 4 |
0.24 0.24 0.32 0.38 |
0.09 0.13 0.16 0.13 |
I - I - I - I |
1.0 1.0 1.3 1.6 |
2 0 1 2 |
0.22 0.04 0.06 0.24 |
0.13 0.05 0.09 0.13 |
I - I - I - I |
1.0 0.2 0.3 1.1 |
Female |
Control 100 200 350 |
72 h 72 h 72 h 72 h |
5 5 5 5 |
1000 1000 1000 1000 |
1000 1000 1000 1000 |
1.44 1.22 0.58 0.72 |
0.19 0.24 0.15 0.15 |
A - (A) * (A) * (A) |
1 1 2 3 |
0.14 0.12 0.24 0.34 |
0.05 0.13 0.11 0.15 |
I - I - I * I |
1.0 0.9 1.7 2.4 |
2 1 2 1 |
0.22 0.14 0.18 0.14 |
0.08 0.09 0.08 0.17 |
I - I - I - I |
1.0 0.6 0.8 0.6 |
Mut.I. = Mutagenic Index = ery with micronuclei in dose group/ery with micronuclei in control
P.Cont. = Positive Control = Endoxan (50 mg/kg bw)
Results in brackets since control lies outside normal range
NT = control not treated
- = no difference from control (p > 0.5)
I = within the normal range
A = outside the normal range
* = significantly different from control (p < 0.5)
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.